Ending Tuberculosis by 2030: Can We Do It?

Hdl Handle:
http://hdl.handle.net/10144/617757
Title:
Ending Tuberculosis by 2030: Can We Do It?
Authors:
Suthar, A B; Zachariah, R; Harries, A D
Journal:
International Journal of Tuberculosis and Lung Disease
Abstract:
The Sustainable Development Goals aim to end tuberculosis (TB) related deaths, transmission and catastrophic costs by 2030. Multisectorial action to accelerate socio-economic development, a new vaccine and novel diagnostics and medicines for treatment are key advances needed to end TB transmission. Achieving 90-90-90 targets for TB (i.e., 90% of vulnerable populations screened, 90% diagnosed and started on treatment, and at least 90% cured) will help accelerate progress towards reductions in mortality; however, passive case detection strategies, multidrug-resistant TB, human immunodeficiency virus coinfection and outdated pathways to care need to be overcome. Ending the catastrophic costs associated with TB will require expansion of health insurance coverage, comprehensive coverage of TB services, and limited indirect costs by vulnerable and poor populations.
Publisher:
International Union Against TB and Lung Disease
Issue Date:
30-Jun-2016
URI:
http://hdl.handle.net/10144/617757
DOI:
10.5588/ijtld.16.0142
Additional Links:
http://www.ingentaconnect.com/content/iuatld/ijtld/pre-prints/content-ijtld.16.0142
Submitted date:
2016-07-12
Language:
en
ISSN:
10273719
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorSuthar, A Ben
dc.contributor.authorZachariah, Ren
dc.contributor.authorHarries, A Den
dc.date.accessioned2016-07-29T19:18:47Z-
dc.date.available2016-07-29T19:18:47Z-
dc.date.issued2016-06-30-
dc.date.submitted2016-07-12-
dc.identifier.citationEnding tuberculosis by 2030: can we do it? 2016 The International Journal of Tuberculosis and Lung Diseaseen
dc.identifier.issn10273719-
dc.identifier.doi10.5588/ijtld.16.0142-
dc.identifier.urihttp://hdl.handle.net/10144/617757-
dc.description.abstractThe Sustainable Development Goals aim to end tuberculosis (TB) related deaths, transmission and catastrophic costs by 2030. Multisectorial action to accelerate socio-economic development, a new vaccine and novel diagnostics and medicines for treatment are key advances needed to end TB transmission. Achieving 90-90-90 targets for TB (i.e., 90% of vulnerable populations screened, 90% diagnosed and started on treatment, and at least 90% cured) will help accelerate progress towards reductions in mortality; however, passive case detection strategies, multidrug-resistant TB, human immunodeficiency virus coinfection and outdated pathways to care need to be overcome. Ending the catastrophic costs associated with TB will require expansion of health insurance coverage, comprehensive coverage of TB services, and limited indirect costs by vulnerable and poor populations.en
dc.language.isoenen
dc.publisherInternational Union Against TB and Lung Diseaseen
dc.relation.urlhttp://www.ingentaconnect.com/content/iuatld/ijtld/pre-prints/content-ijtld.16.0142en
dc.rightsArchived with thanks to The International Journal of Tuberculosis and Lung Diseaseen
dc.titleEnding Tuberculosis by 2030: Can We Do It?en
dc.identifier.journalInternational Journal of Tuberculosis and Lung Diseaseen
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.